DEFINITIVE PROXY STATEMENT

Company

TherapeuticsMD, Inc.

Filed

April 25, 2017

Period of Report

June 16, 2017

Accession Number

0001387131-17-002244

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →